CardioRenal Systems
PrivateLast Round
Corporate Funding
Jul 7, 2026
Total Funding Raised
$15.5M
Company Overview
CardioRenal Systems is a medical device company that develops and markets the RenalPro™ system, a clinically validated solution designed to prevent acute kidney injury (AKI) in hospitalized patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioRenal Systems Comparables
Compare CardioRenal Systems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accuryn Medical | 88% | |
| Renalert LLC | 83% | |
| Serenno Medical | 81% | |
CardioRenal Systems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 7, 2026 | ||||
| Series A | Mar 16, 2017 | ||||
| Debt | Jul 3, 2012 |
Key People
Founding team and executive leadership
CardioRenal Systems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Exigent Capital | Series A |
| Genesis Capital Advisors | Series A |
| Angel Physicians Fund | Corporate Funding |
| Genesis Capital Advisors, LLC | Debt |
CardioRenal Systems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CardioRenal Systems's valuation, stock price, and market status.